https://www.selleckchem.com/pr....oducts/oxythiamine-c
SMA PET imaging and PSMA-directed radioligand therapy warrant further studies in brain tumor patients. PSMA is expressed in glioblastoma both at initial diagnosis and at recurrence. High vascular PSMA expression at recurrence seems to be a negative prognostic marker. Thus, PSMA expression in GBM might present a promising target for theranostic approaches in recurrent glioblastoma. Especially PSMA PET imaging and PSMA-directed radioligand therapy warrant further studies in brain tumor patients.A low NM23-H1 exp
Mi piace
Commento
Condividi
